FDA.reportPublic FDA data

Application 207081

Type
ANDA
Sponsor
AUROBINDO PHARMA LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001KALLIGADESOGESTREL; ETHINYL ESTRADIOLTABLET;ORAL-280.15MG;0.03MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50102-254Cyred EQDesogestrel and Ethinyl EstradiolAfaxys Pharma, LLCANDACurrent
50102-254Cyred EQDesogestrel and Ethinyl EstradiolAfaxys Pharma, LLCANDACurrent
50102-254Cyred EQDesogestrel and Ethinyl EstradiolAfaxys Pharma, LLCANDACurrent
50102-254Cyred EQDesogestrel and Ethinyl EstradiolAfaxys Pharma, LLCANDACurrent
53002-2722Cyred EQDesogestrel and Ethinyl EstradiolRPK Pharmaceuticals, Inc.ANDACurrent
65862-887KalligaDesogestrel and Ethinyl EstradiolAurobindo Pharma LimitedANDACurrent
65862-887KalligaDesogestrel and Ethinyl EstradiolAurobindo Pharma LimitedANDACurrent
65862-887KalligaDesogestrel and Ethinyl EstradiolAurobindo Pharma LimitedANDACurrent
65862-887KalligaDesogestrel and Ethinyl EstradiolAurobindo Pharma LimitedANDACurrent
65862-887KalligaDesogestrel and Ethinyl EstradiolAurobindo Pharma LimitedANDACurrent